Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19

COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlyin...

Full description

Bibliographic Details
Main Authors: Mohammed Talaat Rashid, Waleed Askar, Ahmed Gaafar, Mohamed Fawzy, Mahmoud Abul makarem
Format: Article
Language:English
Published: Society of TURAZ AKADEMI 2020-12-01
Series:Medicine Science
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=105941
id doaj-6482180dccf34b5e81ca5a6dcd8b4ea7
record_format Article
spelling doaj-6482180dccf34b5e81ca5a6dcd8b4ea72021-03-24T11:50:49ZengSociety of TURAZ AKADEMI Medicine Science2147-06342020-12-01941097910.5455/medscience.2020.05.084105941Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19Mohammed Talaat Rashid0Waleed Askar1Ahmed Gaafar2Mohamed Fawzy3Mahmoud Abul makarem4Emergency Medicine Department, Saudi German Hospital, Madina. General Surgery Department, Saudi German Hospital, Madina. Emergency Medicine Department, Saudi German Hospital, Madina. Radiology department, Saudi German Hospital, Madina. General Surgery Department, Saudi German Hospital, MadinaCOVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19. [Med-Science 2020; 9(4.000): 1097-9]http://www.ejmanager.com/fulltextpdf.php?mno=105941covid-19superior mesenteric artery thrombosisacute abdomenhypercoagulability
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Talaat Rashid
Waleed Askar
Ahmed Gaafar
Mohamed Fawzy
Mahmoud Abul makarem
spellingShingle Mohammed Talaat Rashid
Waleed Askar
Ahmed Gaafar
Mohamed Fawzy
Mahmoud Abul makarem
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
Medicine Science
covid-19
superior mesenteric artery thrombosis
acute abdomen
hypercoagulability
author_facet Mohammed Talaat Rashid
Waleed Askar
Ahmed Gaafar
Mohamed Fawzy
Mahmoud Abul makarem
author_sort Mohammed Talaat Rashid
title Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
title_short Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
title_full Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
title_fullStr Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
title_full_unstemmed Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
title_sort superior mesenteric artery thrombosis as a possible presenting complication of covid-19
publisher Society of TURAZ AKADEMI
series Medicine Science
issn 2147-0634
publishDate 2020-12-01
description COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19. [Med-Science 2020; 9(4.000): 1097-9]
topic covid-19
superior mesenteric artery thrombosis
acute abdomen
hypercoagulability
url http://www.ejmanager.com/fulltextpdf.php?mno=105941
work_keys_str_mv AT mohammedtalaatrashid superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19
AT waleedaskar superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19
AT ahmedgaafar superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19
AT mohamedfawzy superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19
AT mahmoudabulmakarem superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19
_version_ 1724204889705283584